Gregory Durm, MD
Hematology & Oncology · Indianapolis, INNPI 1316172299
Payments from drug & device makers
Across 323 payments — averaging $70,338 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$16.1M
- Amgen$3.2M
- AstraZeneca$1.2M
- Eli Lilly$1M
- Boehringer Ingelheim International GmbH$884K
- E.r. Squibb & Sons, L.L.C.$111K
- plus $273K from 10 others
Across 2 payments — averaging $5587.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 80 | $16,097,190 |
| Amgen | 63 | $3,178,632 |
| AstraZeneca | 12 | $1,152,510 |
| Eli Lilly | 14 | $1,021,954 |
| Boehringer Ingelheim International GmbH | 28 | $884,220 |
| E.r. Squibb & Sons, L.L.C. | 22 | $111,113 |
| Day One Biopharmaceuticals | 27 | $105,292 |
| GSK | 26 | $58,336 |
| AbbVie | 20 | $39,215 |
| Novartis | 1 | $20,737 |
| EMD Serono, Inc. | 2 | $15,769 |
| Genentech, Inc. | 14 | $14,256 |
| Deciphera Pharmaceuticals Inc. | 7 | $9,925 |
| Daiichi Sankyo Inc. | 5 | $9,860 |
| G1 Therapeutics, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
How this compares
$22,719,051 in reported general payments places this provider in the 95th percentile of 224 hematology & oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Indianapolis
- Nabil AdraIndianapolis$13.2M
- Attaya SuvannasankhaIndianapolis$8.2M
- Shadia JalalIndianapolis$4.6M
- Ruemu BirhirayIndianapolis$4M
- Richard GaynorIndianapolis$3.7M
- Anand TandraIndianapolis$2.2M
- Brian MulherinIndianapolis$2.2M
- Kathy MillerIndianapolis$1.9M
- Anita TurkIndianapolis$1.5M
- Safi ShahdaIndianapolis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.